UW recently ranked No. 3 in the world for biostatistics graduate programs by U.S. News & World Report (USNWR) in their annual report published April 7. Faculty members Ken Rice and Marco Carone were interviewed as well as current PhD student Bumjun Park.
In the News
The FDA's move to incorporate Bayesian statistical methods into clinical trials of drugs and biologics garnered special treatment in JAMA this week. UW Professor of Biostatistics Thomas Fleming weighs in with his thoughts.
In a new episode of the NIH Collaboratory Podcast, Drs. Jonathan Moyer and David Murray discussed their recent publication, “Evaluating Analytic Models for Individually Randomized Group Treatment Trials With Complex Clustering in Nested and Crossed Designs.” The episode was moderated by Patrick Heagerty, co-chair of the Biostatistics and Study Design core working group and professor of biostatistics at the University of Washington.
University of Washington Professor of Biostatistics Thomas Fleming and Affiliate Professor Holly Hanes reflect on the FDA's recently released draft guidance regarding the use of bayesian methods in clinical trials.
Trump wants the U.S. to ramp up production of glyphosate. The MAHA movement is furious. Lianne Sheppard, Professor of Biostatistics and Environmental and Occupational Health Sciences weighs in on the herbicide’s safety.
The central limit theorem started as a bar trick for 18th-century gamblers. Now scientists rely on it every day. Daniela Witten, Professor of Biostatistics and Statistics at the University of Washington, is quoted.
Infectious disease modeling pioneer helped outline modern precepts for design and analysis of vaccine trials, causal inference with interference; shaped a generation of infectious disease scientists. M. Elizabeth Halloran was a professor with the University of Washington Department of Biostatistics and founder of the Summer Institute in Statistics and Modeling for Infectious Diseases (SISMID).
In this podcast episode Kathleen Kerr, a Professor of Biostatistics at the University of Washington, discusses overdiagnosis and medical decision making. Kerr delves into how patients perceive mammogram results, the difference between overdiagnosis and overcalling, and the challenges pathologists face in diagnosing cancer. She also shares findings from her research on the influence of prior opinions on second diagnoses and the cognitive processes involved in interpreting pathology images. The discussion highlights the complexities and subjectivity in pathology diagnoses and the implications for patient care.